Shanghai INT Medical Instruments Co., Ltd. (INT Medical) has announced that its board of directors will convene on 24 August 2026 in Shanghai. The session’s agenda includes:

1. Approval of the unaudited interim financial results for the six months ended 30 June 2026. 2. Deliberation on the declaration and amount of any interim dividend for shareholders.

The board is chaired by Dr. Liang Dongke and comprises nine directors: two executive directors (Dr. Liang Dongke, Mr. Lin Sen), four non-executive directors (Dr. Song Yuan, Mr. Wang Ruiqin, Ms. Chen Hongqin, Mr. Zhang Hong) and three independent non-executive directors (Mr. Jian Xigao, Mr. Hui Hung Kwan, Mr. Xu Congli).

INT Medical will publish the unaudited interim results following board approval.